Pneumococcal vaccination in adults: a review of the current recommendations

Pneumococcal disease remains a significant cause of morbidity and mortality, particularly in older adults and individuals with underlying medical conditions. To address this public health threat, pneumococcal vaccines have been developed and recommended for use in adult populations. This article provides a comprehensive review of the current recommendations for pneumococcal vaccination in adults and discusses the burden of pneumococcal disease in the adult population, including risk factors for developing the disease. The article concludes with a discussion about future directions for pneumococcal vaccination in adults, including the use of new and improved vaccines, which are developed to ensure wide protection against pneumococcal disease.